We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $817M
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
+16.1%
1 Year Est. Return
+22.58%
3 Year Est. Return
+98.16%
5 Year Est. Return
+143.24%
10 Year Est. Return
+598.39%
AUM
$817M
AUM Growth
+$90.8M
Cap. Flow
+$1.66M
Cap. Flow %
0.2%
Top 10 Hldgs %
63.21%
Holding
81
New
6
Increased
35
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$6.1M
2
BROS icon
Dutch Bros
BROS
+$3.53M
3
LLY icon
Eli Lilly
LLY
+$3.21M
4
ISRG icon
Intuitive Surgical
ISRG
+$2.81M
5
SYK icon
Stryker
SYK
+$2.21M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.38M
2
PAYC icon
Paycom
PAYC
+$5.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$4.55M
4
CRM icon
Salesforce
CRM
+$3.75M
5
NVDA icon
NVIDIA
NVDA
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 39.98%
2 Healthcare 13.64%
3 Consumer Discretionary 12.64%
4 Communication Services 12.29%
5 Financials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
26
American Express
AXP
$214B
$6.99M 0.86%
20,678
+19,049
+1,169% +$6.1M
META icon
27
Meta Platforms (Facebook)
META
$1.73T
$6.83M 0.84%
12,126
-162
-1% -$99.1K
SBUX icon
28
Starbucks
SBUX
$111B
$6.39M 0.78%
62,662
-12,567
-17% -$1.27M
MNST icon
29
Monster Beverage
MNST
$87.6B
$5.93M 0.73%
123,568
+6,474
+6% +$272K
JNJ icon
30
Johnson & Johnson
JNJ
$644B
$5.84M 0.72%
23,002
-171
-0.7% -$39.9K
JPM icon
31
JPMorgan Chase
JPM
$932B
$5.08M 0.62%
15,544
-40
-0.3% -$12.4K
CMG icon
32
Chipotle Mexican Grill
CMG
$43.4B
$4.77M 0.58%
140,314
-139,393
-50% -$4.55M
BROS icon
33
Dutch Bros
BROS
$5.84B
$4.43M 0.54%
+61,521
New +$3.53M
NFLX icon
34
Netflix
NFLX
$322B
$4.25M 0.52%
59,922
+19,673
+49% +$1.73M
HD icon
35
Home Depot
HD
$307B
$3.51M 0.43%
9,950
-976
-9% -$318K
PAYC icon
36
Paycom
PAYC
$10.2B
$3.5M 0.43%
27,756
-40,635
-59% -$5.3M
ASML icon
37
ASML
ASML
$619B
$3.43M 0.42%
1,724
+21
+1% +$33.4K
AZN icon
38
AstraZeneca
AZN
$255B
$2.88M 0.35%
15,165
+891
+6% +$168K
PEP icon
39
PepsiCo
PEP
$185B
$2.81M 0.34%
20,775
-2,224
-10% -$333K
NVO
40
Novo Nordisk
NVO
$188B
$2.77M 0.34%
57,796
-148,553
-72% -$6.38M
REGN icon
41
Regeneron Pharmaceuticals
REGN
$79.9B
$2.55M 0.31%
4,086
-305
-7% -$208K
MCD icon
42
McDonald's
MCD
$176B
$2.45M 0.3%
9,081
-213
-2% -$61.1K
PG icon
43
Procter & Gamble
PG
$342B
$2.35M 0.29%
15,997
-492
-3% -$71.6K
CL icon
44
Colgate-Palmolive
CL
$69.5B
$2.08M 0.26%
22,650
-3,839
-14% -$336K
PAYX icon
45
Paychex
PAYX
$42B
$2M 0.24%
20,359
-17,704
-47% -$1.68M
ADI icon
46
Analog Devices
ADI
$178B
$1.89M 0.23%
4,749
+17
+0.4% +$6.73K
CRM icon
47
Salesforce
CRM
$209B
$1.85M 0.23%
11,779
-21,312
-64% -$3.75M
WMT icon
48
Walmart Inc
WMT
$856B
$1.78M 0.22%
15,775
-297
-2% -$36.9K
ABBV icon
49
AbbVie
ABBV
$464B
$1.77M 0.22%
7,026
+2
+0% +$430
GNRC icon
50
Generac Holdings
GNRC
$10.5B
$1.65M 0.2%
5,628
+60
+1% +$15K

Similar funds

Dillon & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Dillon & Associates held 81 positions worth $817M, up 13% from $726M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Dillon & Associates's Q2 2026 filing shows 6 new, 35 increased, 32 reduced and 1 closed positions. Its largest new stake was Dutch Bros: 61,521 shares worth $4.43M. The largest sale was Novo Nordisk, an estimated $6.38M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q2 2026 buy was Dutch Bros: 61,521 shares worth $4.43M.
  • Dillon & Associates added most to American Express in Q2 2026, an estimated $6.1M increase.
  • Dillon & Associates's biggest Q2 2026 reduction was Novo Nordisk, cutting an estimated $6.38M.
  • Dillon & Associates fully exited Adobe in Q2 2026, selling an estimated $224K.
  • Dillon & Associates's ten largest holdings make up 63% of its $817M portfolio in Q2 2026.
  • Dillon & Associates opened 6 new positions and closed 1 in Q2 2026.
  • Dillon & Associates's portfolio value rose 13% quarter-over-quarter to $817M.

Based on Dillon & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.